Acyclovir in the treatment of herpes viruses–a review

K Kłysik, A Pietraszek, A Karewicz… - Current medicinal …, 2020 - ingentaconnect.com
Background: Herpes Simplex (HSV) viruses are widely spread, highly contagious human
pathogens. The statistics indicate that 50-90% of adults worldwide are seropositive for these …

Role of marine natural products in the genesis of antiviral agents

V Gogineni, RF Schinazi, MT Hamann - Chemical reviews, 2015 - ACS Publications
Mammals have complex biological systems and are constantly prone to infections by a wide
array of bacteria, fungi, viruses, and parasites, a significant challenge to the constant …

[HTML][HTML] The ligand binding mechanism to purine nucleoside phosphorylase elucidated via molecular dynamics and machine learning

S Decherchi, A Berteotti, G Bottegoni… - Nature …, 2015 - nature.com
The study of biomolecular interactions between a drug and its biological target is of
paramount importance for the design of novel bioactive compounds. In this paper, we report …

MolDock applied to structure-based virtual screening

J De Azevedo, F Walter - Current drug targets, 2010 - ingentaconnect.com
Molecular docking is a simulation process where the binding of a small molecule is
identified in the structure of a protein target. There are several different computational …

[HTML][HTML] The use of biodiversity as source of new chemical entities against defined molecular targets for treatment of malaria, tuberculosis, and T-cell mediated …

LA Basso, LHP Silva, AG Fett-Neto… - Memórias do Instituto …, 2005 - SciELO Brasil
The modern approach to the development of new chemical entities against complex
diseases, especially the neglected endemic diseases such as tuberculosis and malaria, is …

A pipeline to enhance ligand virtual screening: integrating molecular dynamics and fingerprints for ligand and proteins

F Spyrakis, P Benedetti, S Decherchi… - Journal of Chemical …, 2015 - ACS Publications
The importance of taking into account protein flexibility in drug design and virtual ligand
screening (VS) has been widely debated in the literature, and molecular dynamics (MD) has …

A proof-of-principle pharmacokinetic, pharmacodynamic, and clinical study with purine nucleoside phosphorylase inhibitor immucillin-H (BCX-1777, forodesine)

V Gandhi, JM Kilpatrick, W Plunkett, M Ayres, L Harman… - Blood, 2005 - ashpublications.org
The discovery of purine nucleoside phosphorylase (PNP) deficiency and T lymphocytopenia
suggested that inhibition of this enzyme could serve as a therapeutic target. Inhibitors of …

Recent progress of molecular docking simulations applied to development of drugs

L Santana Azevedo, F Pretto Moraes… - Current …, 2012 - ingentaconnect.com
In order to obtain structural information about intermolecular interactions between a protein
target and a drug we could either solve the structure by experimental techniques (protein …

Purine salvage pathway in Mycobacterium tuberculosis

RG Ducati, A Breda, LA Basso… - Current medicinal …, 2011 - ingentaconnect.com
Millions of deaths worldwide are caused by the aetiological agent of tuberculosis,
Mycobacterium tuberculosis. The increasing prevalence of this disease, the emergence of …

Influence of bone marrow stromal microenvironment on forodesine-induced responses in CLL primary cells

K Balakrishnan, JA Burger, MP Quiroga… - Blood, The Journal …, 2010 - ashpublications.org
Forodesine, a purine nucleoside phosphorylase inhibitor, displays in vitro activity in chronic
lymphocytic leukemia (CLL) cells in presence of dGuo, which is the basis for an ongoing …